| # | Drug | Count |
|---|---|---|
| 0 | ACETYLCYSTEINE | 2 |
| 1 | ALBUTEROL | 2 |
| 2 | ALBUTEROL SULFATE | 2 |
| 3 | ASPIRIN | 2 |
| 4 | ASPIRIN 325 MG | 2 |
| 5 | ASPIRIN 81 MG | 2 |
| 6 | CARVEDILOL | 2 |
| 7 | DALTEPARIN SODIUM | 2 |
| 8 | PANTOPRAZOLE | 2 |
| 9 | TORSEMIDE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLOXURIDINE | 1 | 0.0058 |
| 1 | TRIMIPRAMINE | 2 | 0.0018 |
| 2 | ACETYLCYSTEINE | 2 | 0.0002 |
| 3 | DALTEPARIN SODIUM | 2 | 0.0002 |
| 4 | RAMUCIRUMAB | 1 | 0.0002 |
| 5 | PEGFILGRASTIM | 1 | 0.0001 |
| 6 | ROMIPLOSTIM | 1 | 0.0001 |
| 7 | PANITUMUMAB | 1 | 0.0001 |
| 8 | TORSEMIDE | 2 | 0.0001 |
| 9 | DURVALUMAB | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Antidote [EPC] | 2 |
| 1 | Antidote for Acetaminophen Overdose [EPC] | 2 |
| 2 | Loop Diuretic [EPC] | 2 |
| 3 | Mucolytic [EPC] | 2 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 2 |
| 6 | Platinum-based Drug [EPC] | 2 |
| 7 | alpha-Adrenergic Blocker [EPC] | 2 |
| 8 | beta-Adrenergic Blocker [EPC] | 2 |
| 9 | Antimetabolite [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 1 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 2 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 3 | Antidote [EPC] | 2 | 0.0000 |
| 4 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | alpha-Adrenergic Blocker [EPC] | 2 | 0.0000 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 2 | 0.0000 |
| 8 | Leukocyte Growth Factor [EPC] | 1 | 0.0000 |
| 9 | beta-Adrenergic Blocker [EPC] | 2 | 0.0000 |